Ignite Creation Date:
2024-05-06 @ 10:38 AM
Last Modification Date:
2024-10-26 @ 12:33 PM
Study NCT ID:
NCT03311542
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2018-01-10
First Post:
2017-10-12
Brief Title:
Expanded Access for Pembrolizumab MK-3475
Sponsor:
Center Trials Treatment
Organization:
Center Trials Treatment
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2017-10-12
First Submit QC Date:
October 12 2017
Study First Post Date:
2017-10-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-09
Last Update Post Date:
2018-01-10
Last Update Post Date Type:
ACTUAL